Achilles Therapeutics PLC ADR (ACHL) Financials

$1.48

$0.00 (0.00%)

As on 26-Mar-2025 09:30EDT

Market cap

$63 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	2.36	4.73	3.69	3.29	0.78	0.30
Gross Profit	-2.36	-4.73	-3.69	-3.29	-0.78	-0.30
Operating Expenses	70.84	75.26	78.38	64.20	33.73	13.78
Operating Profit (EBIT)	-72.02	-75.26	-78.38	-64.20	-33.73	-13.78
Other Income	--	--	--	--	--	--
Profit before Tax	-66.39	-69.17	-71.07	-61.06	-33.20	-13.99
Provision for Tax	-0.02	0.49	0.11	0.04	0.00	0.13
Profit after Tax (Net Income)	-66.87	-69.67	-71.18	-61.10	-33.20	-13.99
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-71.18	-61.10	-33.20	-13.99

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	103.14	142.37	197.04	289.53	189.37	101.35
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1.07	2.09	5.32	8.47	12.92	1.39
Current Liabilities	18.47	17.00	17.99	19.11	16.62	3.86
Total Liabilities	141.15	161.46	220.36	317.11	218.92	105.21

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	11.05	15.82	23.78	32.36	31.12	2.14
Current Assets	111.63	145.63	196.58	284.75	187.80	103.06
Total Assets	141.15	161.46	220.36	317.11	218.92	105.21
Total Debt*	3.62	4.62	8.58	12.26	15.98	0.49
Net Current Assets	93.16	128.64	178.59	265.64	171.17	99.20

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-48.45	-59.54	-59.28	-25.25	-14.14
Cash Flow from Investing Activities	--	--	-7.51	-7.63	-11.85	-0.94
Cash from Financing Activities	--	0.01	0.00	0.16	113.70	93.62
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	-1.67	-1.74	-1.83	-2.11	-33.20	--
Cash EPS ($)	--	-1.63	-1.73	-1.99	-32.43	--
Adjusted Book Value ($)	--	3.56	5.05	9.98	189.37	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.21	-1.53	-2.04	-25.25	--
Free Cash Flow per Share ($)	--	-1.24	-1.72	-2.31	-37.10	--

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-39.51	-28.05	-24.10	-21.61	-24.43
ROE (%)	-57.28	-41.05	-29.26	-25.52	-22.84	-24.54
ROA (%)	-39.96	-36.49	-26.49	-22.80	-20.49	-23.48
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	59.87	8.40	-34.42	-80.99	-144.86	-99.63
Net Profit Growth (%)	10.95	2.12	-16.49	-84.04	-137.31	-103.14
EPS Growth (%)	11.67	0.05	0.13	0.94	--	--
Book Value Growth (%)	-32.80	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	-0.51	-0.49	-2.38	--	--
Price / Book Value	0.61	0.25	0.18	0.50	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	1.66	1.30	1.65	1.88	--	--
Close Price ($)	1.02	0.89	0.90	5.01	--	--
High Price ($)	1.76	1.37	5.35	18.95	--	--
Low Price ($)	0.63	0.74	0.75	4.12	--	--
Market Cap ($ Cr)	63.22	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	0.03	0.04	0.04	0.08	0.00
Short term debt to equity ratio	0.04	0.02	0.02	0.02	0.02	0.00
Current Ratio	6.04	8.57	10.93	14.90	11.30	26.72
Quick Ratio	6.04	8.57	10.67	14.63	11.19	26.59
Interest Coverage	--	--	-11.21	-19.49	-63.53	-64.08

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	178.48	483.19	382.79	530.97	607.04
Payable days	--	417.49	441.20	557.49	1,693.85	620.89
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.